- Population
The population density of North Falmouth, MA was 825 in 2009.
Population Density
Population Density is computed by dividing the total population by Land Area Per Square Mile.
Above charts are based on data from the U.S. Census American Community Survey | ODN Dataset | API -
Geographic and Population Datasets Involving North Falmouth, MA
- API
Bronx Zip Population and Density
bronx.lehman.cuny.edu | Last Updated 2012-10-21T14:06:17.000Z2010 Census Data on population, pop density, age and ethnicity per zip code
- API
Rates of COVID-19 Cases or Deaths by Age Group and Vaccination Status
data.cdc.gov | Last Updated 2023-07-20T16:01:58.000ZData for CDC’s COVID Data Tracker site on Rates of COVID-19 Cases and Deaths by Vaccination Status. Click 'More' for important dataset description and footnotes Dataset and data visualization details: These data were posted on October 21, 2022, archived on November 18, 2022, and revised on February 22, 2023. These data reflect cases among persons with a positive specimen collection date through September 24, 2022, and deaths among persons with a positive specimen collection date through September 3, 2022. Vaccination status: A person vaccinated with a primary series had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after verifiably completing the primary series of an FDA-authorized or approved COVID-19 vaccine. An unvaccinated person had SARS-CoV-2 RNA or antigen detected on a respiratory specimen and has not been verified to have received COVID-19 vaccine. Excluded were partially vaccinated people who received at least one FDA-authorized vaccine dose but did not complete a primary series ≥14 days before collection of a specimen where SARS-CoV-2 RNA or antigen was detected. Additional or booster dose: A person vaccinated with a primary series and an additional or booster dose had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after receipt of an additional or booster dose of any COVID-19 vaccine on or after August 13, 2021. For people ages 18 years and older, data are graphed starting the week including September 24, 2021, when a COVID-19 booster dose was first recommended by CDC for adults 65+ years old and people in certain populations and high risk occupational and institutional settings. For people ages 12-17 years, data are graphed starting the week of December 26, 2021, 2 weeks after the first recommendation for a booster dose for adolescents ages 16-17 years. For people ages 5-11 years, data are included starting the week of June 5, 2022, 2 weeks after the first recommendation for a booster dose for children aged 5-11 years. For people ages 50 years and older, data on second booster doses are graphed starting the week including March 29, 2022, when the recommendation was made for second boosters. Vertical lines represent dates when changes occurred in U.S. policy for COVID-19 vaccination (details provided above). Reporting is by primary series vaccine type rather than additional or booster dose vaccine type. The booster dose vaccine type may be different than the primary series vaccine type. ** Because data on the immune status of cases and associated deaths are unavailable, an additional dose in an immunocompromised person cannot be distinguished from a booster dose. This is a relevant consideration because vaccines can be less effective in this group. Deaths: A COVID-19–associated death occurred in a person with a documented COVID-19 diagnosis who died; health department staff reviewed to make a determination using vital records, public health investigation, or other data sources. Rates of COVID-19 deaths by vaccination status are reported based on when the patient was tested for COVID-19, not the date they died. Deaths usually occur up to 30 days after COVID-19 diagnosis. Participating jurisdictions: Currently, these 31 health departments that regularly link their case surveillance to immunization information system data are included in these incidence rate estimates: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Idaho, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Michigan, Minnesota, Nebraska, New Jersey, New Mexico, New York, New York City (New York), North Carolina, Philadelphia (Pennsylvania), Rhode Island, South Dakota, Tennessee, Texas, Utah, Washington, and West Virginia; 30 jurisdictions also report deaths among vaccinated and unvaccinated people. These jurisdictions represent 72% of the total U.S. population and all ten of the Health and Human Services Regions. Data on cases
- API
Rates of COVID-19 Cases or Deaths by Age Group and Vaccination Status and Booster Dose
data.cdc.gov | Last Updated 2023-06-09T00:47:32.000ZData for CDC’s COVID Data Tracker site on Rates of COVID-19 Cases and Deaths by Vaccination Status. Click 'More' for important dataset description and footnotes Dataset and data visualization details: These data were posted on October 21, 2022, archived on November 18, 2022, and revised on February 22, 2023. These data reflect cases among persons with a positive specimen collection date through September 24, 2022, and deaths among persons with a positive specimen collection date through September 3, 2022. Vaccination status: A person vaccinated with a primary series had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after verifiably completing the primary series of an FDA-authorized or approved COVID-19 vaccine. An unvaccinated person had SARS-CoV-2 RNA or antigen detected on a respiratory specimen and has not been verified to have received COVID-19 vaccine. Excluded were partially vaccinated people who received at least one FDA-authorized vaccine dose but did not complete a primary series ≥14 days before collection of a specimen where SARS-CoV-2 RNA or antigen was detected. Additional or booster dose: A person vaccinated with a primary series and an additional or booster dose had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after receipt of an additional or booster dose of any COVID-19 vaccine on or after August 13, 2021. For people ages 18 years and older, data are graphed starting the week including September 24, 2021, when a COVID-19 booster dose was first recommended by CDC for adults 65+ years old and people in certain populations and high risk occupational and institutional settings. For people ages 12-17 years, data are graphed starting the week of December 26, 2021, 2 weeks after the first recommendation for a booster dose for adolescents ages 16-17 years. For people ages 5-11 years, data are included starting the week of June 5, 2022, 2 weeks after the first recommendation for a booster dose for children aged 5-11 years. For people ages 50 years and older, data on second booster doses are graphed starting the week including March 29, 2022, when the recommendation was made for second boosters. Vertical lines represent dates when changes occurred in U.S. policy for COVID-19 vaccination (details provided above). Reporting is by primary series vaccine type rather than additional or booster dose vaccine type. The booster dose vaccine type may be different than the primary series vaccine type. ** Because data on the immune status of cases and associated deaths are unavailable, an additional dose in an immunocompromised person cannot be distinguished from a booster dose. This is a relevant consideration because vaccines can be less effective in this group. Deaths: A COVID-19–associated death occurred in a person with a documented COVID-19 diagnosis who died; health department staff reviewed to make a determination using vital records, public health investigation, or other data sources. Rates of COVID-19 deaths by vaccination status are reported based on when the patient was tested for COVID-19, not the date they died. Deaths usually occur up to 30 days after COVID-19 diagnosis. Participating jurisdictions: Currently, these 31 health departments that regularly link their case surveillance to immunization information system data are included in these incidence rate estimates: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Idaho, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Michigan, Minnesota, Nebraska, New Jersey, New Mexico, New York, New York City (New York), North Carolina, Philadelphia (Pennsylvania), Rhode Island, South Dakota, Tennessee, Texas, Utah, Washington, and West Virginia; 30 jurisdictions also report deaths among vaccinated and unvaccinated people. These jurisdictions represent 72% of the total U.S. population and all ten of the Health and Human Services Regions. Data on cases
- API
Incidence Rate Of Leukemia Per 100,000 All States
opendata.utah.gov | Last Updated 2019-04-19T00:30:16.000ZIncidence Rate Of Leukemia Per 100,000 All States
- API
Cambridge Vaccine Demographics by Week 3/18/2021-3/29/2023 (Historical)
data.cambridgema.gov | Last Updated 2024-04-18T20:27:52.000ZThis open dataset shows data on Cambridge residents who have received a COVID-19 vaccine at any location (e.g., mass vaccination site, pharmacy, doctor's office). These data come from the Massachusetts Department of Public Health's weekly report on vaccine doses administered by municipality. The report is released on Thursdays. This open dataset includes data going back several weeks and complements another open dataset called "Cambridge Vaccine Demographics," which shows data for the latest week (https://data.cambridgema.gov/Public-Health/Cambridge-Vaccination-Demographics/66td-u88k) The Moderna and Pfizer vaccines require two doses administered at least 28 days apart in order to be fully vaccinated. The J&J (Janssen) vaccine requires a single dose in order to be fully vaccinated. The category "Residents Who Received at Least One Dose" reflects the total number of individuals in the fully and partially vaccinated categories. That is, this category comprises individuals who have received one or both doses of the Moderna/Pfizer vaccine or have received the single dose J&J (Janssen) vaccine. The category "Fully Vaccinated Residents" comprises individuals who have received both doses of the Moderna/ Pfizer vaccine or the single-dose J&J vaccine. The category "Partially Vaccinated Residents" comprises individuals who have received only the first dose of the Moderna/Pfizer vaccine. Source: Weekly COVID-19 Municipality Vaccination Report. Massachusetts releases updated data each Thursday at 5 p.m.
- API
FY2021 NCVAS Facilities Data Summary Including Territories for 2023 State Summaries
www.datahub.va.gov | Last Updated 2024-08-25T21:51:53.000ZFY 2021 VA facilities data used to populate the NCVAS State summaries created in FY2023.
- API
Provisional COVID-19 death counts and rates by month, jurisdiction of residence, and demographic characteristics
data.cdc.gov | Last Updated 2024-10-17T15:00:18.000ZThis file contains COVID-19 death counts and rates by month and year of death, jurisdiction of residence (U.S., HHS Region) and demographic characteristics (sex, age, race and Hispanic origin, and age/race and Hispanic origin). United States death counts and rates include the 50 states, plus the District of Columbia. Deaths with confirmed or presumed COVID-19, coded to ICD–10 code U07.1. Number of deaths reported in this file are the total number of COVID-19 deaths received and coded as of the date of analysis and may not represent all deaths that occurred in that period. Counts of deaths occurring before or after the reporting period are not included in the file. Data during recent periods are incomplete because of the lag in time between when the death occurred and when the death certificate is completed, submitted to NCHS and processed for reporting purposes. This delay can range from 1 week to 8 weeks or more, depending on the jurisdiction and cause of death. Death counts should not be compared across jurisdictions. Data timeliness varies by state. Some states report deaths on a daily basis, while other states report deaths weekly or monthly. The ten (10) United States Department of Health and Human Services (HHS) regions include the following jurisdictions. Region 1: Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont; Region 2: New Jersey, New York; Region 3: Delaware, District of Columbia, Maryland, Pennsylvania, Virginia, West Virginia; Region 4: Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina, Tennessee; Region 5: Illinois, Indiana, Michigan, Minnesota, Ohio, Wisconsin; Region 6: Arkansas, Louisiana, New Mexico, Oklahoma, Texas; Region 7: Iowa, Kansas, Missouri, Nebraska; Region 8: Colorado, Montana, North Dakota, South Dakota, Utah, Wyoming; Region 9: Arizona, California, Hawaii, Nevada; Region 10: Alaska, Idaho, Oregon, Washington. Rates were calculated using the population estimates for 2021, which are estimated as of July 1, 2021 based on the Blended Base produced by the US Census Bureau in lieu of the April 1, 2020 decennial population count. The Blended Base consists of the blend of Vintage 2020 postcensal population estimates, 2020 Demographic Analysis Estimates, and 2020 Census PL 94-171 Redistricting File (see https://www2.census.gov/programs-surveys/popest/technical-documentation/methodology/2020-2021/methods-statement-v2021.pdf). Rate are based on deaths occurring in the specified week and are age-adjusted to the 2000 standard population using the direct method (see https://www.cdc.gov/nchs/data/nvsr/nvsr70/nvsr70-08-508.pdf). These rates differ from annual age-adjusted rates, typically presented in NCHS publications based on a full year of data and annualized weekly age-adjusted rates which have been adjusted to allow comparison with annual rates. Annualization rates presents deaths per year per 100,000 population that would be expected in a year if the observed period specific (weekly) rate prevailed for a full year. Sub-national death counts between 1-9 are suppressed in accordance with NCHS data confidentiality standards. Rates based on death counts less than 20 are suppressed in accordance with NCHS standards of reliability as specified in NCHS Data Presentation Standards for Proportions (available from: https://www.cdc.gov/nchs/data/series/sr_02/sr02_175.pdf.).
- API
Vital Signs: Population – Bay Area
data.bayareametro.gov | Last Updated 2020-04-13T23:14:07.000ZVITAL SIGNS INDICATOR Population (LU1) FULL MEASURE NAME Population estimates LAST UPDATED October 2019 DESCRIPTION Population is a measurement of the number of residents that live in a given geographical area, be it a neighborhood, city, county or region. DATA SOURCES U.S Census Bureau: Decennial Census No link available (1960-1990) http://factfinder.census.gov (2000-2010) California Department of Finance: Population and Housing Estimates Table E-6: County Population Estimates (1961-1969) Table E-4: Population Estimates for Counties and State (1971-1989) Table E-8: Historical Population and Housing Estimates (2001-2018) Table E-5: Population and Housing Estimates (2011-2019) http://www.dof.ca.gov/Forecasting/Demographics/Estimates/ U.S. Census Bureau: Decennial Census - via Longitudinal Tract Database Spatial Structures in the Social Sciences, Brown University Population Estimates (1970 - 2010) http://www.s4.brown.edu/us2010/index.htm U.S. Census Bureau: American Community Survey 5-Year Population Estimates (2011-2017) http://factfinder.census.gov U.S. Census Bureau: Intercensal Estimates Estimates of the Intercensal Population of Counties (1970-1979) Intercensal Estimates of the Resident Population (1980-1989) Population Estimates (1990-1999) Annual Estimates of the Population (2000-2009) Annual Estimates of the Population (2010-2017) No link available (1970-1989) http://www.census.gov/popest/data/metro/totals/1990s/tables/MA-99-03b.txt http://www.census.gov/popest/data/historical/2000s/vintage_2009/metro.html https://www.census.gov/data/datasets/time-series/demo/popest/2010s-total-metro-and-micro-statistical-areas.html CONTACT INFORMATION vitalsigns.info@bayareametro.gov METHODOLOGY NOTES (across all datasets for this indicator) All legal boundaries and names for Census geography (metropolitan statistical area, county, city, and tract) are as of January 1, 2010, released beginning November 30, 2010, by the U.S. Census Bureau. A Priority Development Area (PDA) is a locally-designated area with frequent transit service, where a jurisdiction has decided to concentrate most of its housing and jobs growth for development in the foreseeable future. PDA boundaries are current as of August 2019. For more information on PDA designation see http://gis.abag.ca.gov/website/PDAShowcase/. Population estimates for Bay Area counties and cities are from the California Department of Finance, which are as of January 1st of each year. Population estimates for non-Bay Area regions are from the U.S. Census Bureau. Decennial Census years reflect population as of April 1st of each year whereas population estimates for intercensal estimates are as of July 1st of each year. Population estimates for Bay Area tracts are from the decennial Census (1970 -2010) and the American Community Survey (2008-2012 5-year rolling average; 2010-2014 5-year rolling average; 2013-2017 5-year rolling average). Estimates of population density for tracts use gross acres as the denominator. Population estimates for Bay Area PDAs are from the decennial Census (1970 - 2010) and the American Community Survey (2006-2010 5 year rolling average; 2010-2014 5-year rolling average; 2013-2017 5-year rolling average). Population estimates for PDAs are derived from Census population counts at the tract level for 1970-1990 and at the block group level for 2000-2017. Population from either tracts or block groups are allocated to a PDA using an area ratio. For example, if a quarter of a Census block group lies with in a PDA, a quarter of its population will be allocated to that PDA. Tract-to-PDA and block group-to-PDA area ratios are calculated using gross acres. Estimates of population density for PDAs use gross acres as the denominator. Annual population estimates for metropolitan areas outside the Bay Area are from the Census and are benchmarked to each decennial Census. The annual estimates in the 1990s were not updated to match the 2000 benchmark. The followi
- API
Vital Signs: Population – by tract
data.bayareametro.gov | Last Updated 2020-04-13T23:07:46.000ZVITAL SIGNS INDICATOR Population (LU1) FULL MEASURE NAME Population estimates LAST UPDATED March 2020 DESCRIPTION Population is a measurement of the number of residents that live in a given geographical area, be it a neighborhood, city, county or region. DATA SOURCES U.S Census Bureau: Decennial Census No link available (1960-1990) http://factfinder.census.gov (2000-2010) California Department of Finance: Population and Housing Estimates Table E-6: County Population Estimates (1961-1969) Table E-4: Population Estimates for Counties and State (1971-1989) Table E-8: Historical Population and Housing Estimates (2001-2018) Table E-5: Population and Housing Estimates (2011-2019) http://www.dof.ca.gov/Forecasting/Demographics/Estimates/ U.S. Census Bureau: Decennial Census - via Longitudinal Tract Database Spatial Structures in the Social Sciences, Brown University Population Estimates (1970 - 2010) http://www.s4.brown.edu/us2010/index.htm U.S. Census Bureau: American Community Survey 5-Year Population Estimates (2011-2018) http://factfinder.census.gov U.S. Census Bureau: Intercensal Estimates Estimates of the Intercensal Population of Counties (1970-1979) Intercensal Estimates of the Resident Population (1980-1989) Population Estimates (1990-1999) Annual Estimates of the Population (2000-2009) Annual Estimates of the Population (2010-2018) No link available (1970-1989) http://www.census.gov/popest/data/metro/totals/1990s/tables/MA-99-03b.txt http://www.census.gov/popest/data/historical/2000s/vintage_2009/metro.html https://www.census.gov/data/datasets/time-series/demo/popest/2010s-total-metro-and-micro-statistical-areas.html CONTACT INFORMATION vitalsigns.info@bayareametro.gov METHODOLOGY NOTES (across all datasets for this indicator) All legal boundaries and names for Census geography (metropolitan statistical area, county, city, and tract) are as of January 1, 2010, released beginning November 30, 2010, by the U.S. Census Bureau. A Priority Development Area (PDA) is a locally-designated area with frequent transit service, where a jurisdiction has decided to concentrate most of its housing and jobs growth for development in the foreseeable future. PDA boundaries are current as of August 2019. For more information on PDA designation see http://gis.abag.ca.gov/website/PDAShowcase/. Population estimates for Bay Area counties and cities are from the California Department of Finance, which are as of January 1st of each year. Population estimates for non-Bay Area regions are from the U.S. Census Bureau. Decennial Census years reflect population as of April 1st of each year whereas population estimates for intercensal estimates are as of July 1st of each year. Population estimates for Bay Area tracts are from the decennial Census (1970 -2010) and the American Community Survey (2008-2012 5-year rolling average; 2010-2014 5-year rolling average; 2013-2017 5-year rolling average). Estimates of population density for tracts use gross acres as the denominator. Population estimates for Bay Area PDAs are from the decennial Census (1970 - 2010) and the American Community Survey (2006-2010 5 year rolling average; 2010-2014 5-year rolling average; 2013-2017 5-year rolling average). Population estimates for PDAs are derived from Census population counts at the tract level for 1970-1990 and at the block group level for 2000-2018. Population from either tracts or block groups are allocated to a PDA using an area ratio. For example, if a quarter of a Census block group lies with in a PDA, a quarter of its population will be allocated to that PDA. Tract-to-PDA and block group-to-PDA area ratios are calculated using gross acres. Estimates of population density for PDAs use gross acres as the denominator. Annual population estimates for metropolitan areas outside the Bay Area are from the Census and are benchmarked to each decennial Census. The annual estimates in the 1990s were not updated to match the 2000 benchmark. The following is a l
- API
Vital Signs: Population – by city
data.bayareametro.gov | Last Updated 2021-10-06T03:56:01.000ZVITAL SIGNS INDICATOR Population (LU1) FULL MEASURE NAME Population estimates LAST UPDATED October 2019 DESCRIPTION Population is a measurement of the number of residents that live in a given geographical area, be it a neighborhood, city, county or region. DATA SOURCES U.S Census Bureau: Decennial Census No link available (1960-1990) http://factfinder.census.gov (2000-2010) California Department of Finance: Population and Housing Estimates Table E-6: County Population Estimates (1961-1969) Table E-4: Population Estimates for Counties and State (1971-1989) Table E-8: Historical Population and Housing Estimates (2001-2018) Table E-5: Population and Housing Estimates (2011-2019) http://www.dof.ca.gov/Forecasting/Demographics/Estimates/ U.S. Census Bureau: Decennial Census - via Longitudinal Tract Database Spatial Structures in the Social Sciences, Brown University Population Estimates (1970 - 2010) http://www.s4.brown.edu/us2010/index.htm U.S. Census Bureau: American Community Survey 5-Year Population Estimates (2011-2017) http://factfinder.census.gov U.S. Census Bureau: Intercensal Estimates Estimates of the Intercensal Population of Counties (1970-1979) Intercensal Estimates of the Resident Population (1980-1989) Population Estimates (1990-1999) Annual Estimates of the Population (2000-2009) Annual Estimates of the Population (2010-2017) No link available (1970-1989) http://www.census.gov/popest/data/metro/totals/1990s/tables/MA-99-03b.txt http://www.census.gov/popest/data/historical/2000s/vintage_2009/metro.html https://www.census.gov/data/datasets/time-series/demo/popest/2010s-total-metro-and-micro-statistical-areas.html CONTACT INFORMATION vitalsigns.info@bayareametro.gov METHODOLOGY NOTES (across all datasets for this indicator) All legal boundaries and names for Census geography (metropolitan statistical area, county, city, and tract) are as of January 1, 2010, released beginning November 30, 2010, by the U.S. Census Bureau. A Priority Development Area (PDA) is a locally-designated area with frequent transit service, where a jurisdiction has decided to concentrate most of its housing and jobs growth for development in the foreseeable future. PDA boundaries are current as of August 2019. For more information on PDA designation see http://gis.abag.ca.gov/website/PDAShowcase/. Population estimates for Bay Area counties and cities are from the California Department of Finance, which are as of January 1st of each year. Population estimates for non-Bay Area regions are from the U.S. Census Bureau. Decennial Census years reflect population as of April 1st of each year whereas population estimates for intercensal estimates are as of July 1st of each year. Population estimates for Bay Area tracts are from the decennial Census (1970 -2010) and the American Community Survey (2008-2012 5-year rolling average; 2010-2014 5-year rolling average; 2013-2017 5-year rolling average). Estimates of population density for tracts use gross acres as the denominator. Population estimates for Bay Area PDAs are from the decennial Census (1970 - 2010) and the American Community Survey (2006-2010 5 year rolling average; 2010-2014 5-year rolling average; 2013-2017 5-year rolling average). Population estimates for PDAs are derived from Census population counts at the tract level for 1970-1990 and at the block group level for 2000-2017. Population from either tracts or block groups are allocated to a PDA using an area ratio. For example, if a quarter of a Census block group lies with in a PDA, a quarter of its population will be allocated to that PDA. Tract-to-PDA and block group-to-PDA area ratios are calculated using gross acres. Estimates of population density for PDAs use gross acres as the denominator. Annual population estimates for metropolitan areas outside the Bay Area are from the Census and are benchmarked to each decennial Census. The annual estimates in the 1990s were not updated to match the 2000 benchmark. The following is a